The effect of various inflammatory agents on the phagocytosis and cytokine profile of mouse and rat macrophages

Inflammation Research

Volumn 57, Issue 2, 2008, Pages 75-83

  Hrabak A ^a   Bajor, T ^b   Csuka, I ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Kaba Elzett Rt   (Hungary)

Author keywords

Arginase; Inflammation; Macrophages; Nitric oxide; Th 1 Th 2 cytokines

Indexed keywords

ARGINASE; BCG VACCINE; CARRAGEENAN; CASEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MACROPHAGE FUNCTION; MALE; MICROCOCCUS LUTEUS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RAT;

ANIMALS; ARGINASE; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; MICE; MICROCOCCUS LUTEUS; NITRIC OXIDE; PHAGOCYTOSIS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749123213     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7057-7     Document Type: Article

References (45)

1. Krumenacker JS, Hanafy KA, Murad F. Regulation of nitric oxide and soluble guanylyl cyclase. Brain Res Bull 2004; 62: 50515
2. Costa VM, Torres KC, Mendonca RZ, Gresser I, Gollob KJ, Abrahamsohn IA. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol 2006; 177: 3193-200.
3. Kelley ST, Menon C, Buerk DG, Bauer TW, Fraker DL. Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. Surgery 2002; 132: 252-8.
4. Mocellin S, Bronte V, Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev 2007; 27: 317-52.
5. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005; 54 Suppl 2: S97-107.
6. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Resp Crit Care Med 2000; 161: 1781-5.
7. Hallemeesch MM, Lamers WH, Deutz NE. Reduced arginine availability and nitric oxide production. Clin Nutr 2002; 21: 273-9.
8. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54: 469-87.
9. Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharmaceut Design 2006; 12: 3551-70.
10. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-50.
11. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 2006; 281: 38376-84.
12. Corraliza I, Moncada S. Increased expression of arginase II in patients with different forms of arthritis. Implications of the regulation of nitric oxide. J Rheumatol 2002; 29: 2261-5.
13. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotypes. J Immunol 1998; 160: 5347-54.
14. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995; 25: 1101-4.
15. Hrabák A, Temesi Á, Csuka I, Antoni F. Inverse relation in the de novo arginase synthesis and nitric oxide production in murine and rat peritoneal macrophages in long-term cultures in vivo. Comp Biochem Physiol 1992; 103B: 839-45.
16. Chatterjee S, Premachandran S, Bagewadikar RS, Bhattacharya S, Chattopadhyay S, Poduval TB. Arginine metabolic pathways determine its therapeutic benefit in experimental heatstroke: role of Th1/Th2 cytokine balance. Nitric Oxide. 2006; 15: 408-16.
17. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-12.
18. Faust D, Loos M. In vitro modulation of C1q mRNA expression and secretion by interleukin-1, interleukin-6 and interferon-gamma in resident and stimulated murine peritoneal macrophages. Immunobiology 2002; 206: 368-76.
19. Metcalf D. The molecular control of granulocytes and macrophages. Ciba Found Symp 1997; 204: 40-50.
20. Hrabák A, Bajor T, Csuka I. The effect of various inflammatory agents on the alternative metabolic pathways of arginine in mouse and rat macrophages. Inflamm Res 2006; 55, 23-31.
21. Davies JQ, Gordon S. Isolation and culture of murine macrophages. Methods in Mol Biol 2005; 290: 91-103.
22. Miyamoto M, Sato EF, Nishikawa M, Nishizawa Y, Morii H, Inoue M. Effect of endogenously generated nitric oxide on the energy metabolism of peritoneal macrophages. Physiol Chem Phys Med NMR 2003; 35: 1-11.
23. Conde M, Andrade J, Bedoya FJ, Santa Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology 1995; 84: 476-81.
24. Nacife VP, Soeiro MdeN, Gomes RN, D'Avila H, Castro-Faria Neto HC, Meirelles MdeN. Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Struct Func 2004; 29: 27-34.
25. Cuzzocrea S, Mazzon E, Sautebin L, Serraino I, Dugo L, Calabro G et al. The protective role of endogeneous estrogens in carrageenan-induced lung injury in the rat. Mol Med 2001; 7: 478-87.
26. Luo Y, Yamada H, Evanoff DP, Chen X. Role of Th-1 stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells. Clin Exp Immunol 2006; 146: 181-8.
27. Nascimento FR, Ribeiro-Dias F, Russo M. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz J Med Biol Res 1998; 31: 1593-6.
28. Werneck-Barroso E, Novaes Moura AC, Dias Fernandes P, Crus Rosas E, Assreuy J, das Gracas MO et al. Nitric oxide production by BCG-infected pleural macrophages from C57B1/6 and DBA-2 mice. Int J Mol Med 2000; 5: 95-9.
29. Hrabák A, Csuka I, Bajor T, Csatáry LK. The cytotoxic anti-tumor effect of MTH-68/H, a live attenuated Newcastle Disease Virus is mediated by the induction of nitric oxide synthesis in rat peritoneal macrophages in vitro. Cancer Lett 2006; 231, 279-89.
30. Schirrmacher V, Bai L, Umansky V, Yu L, Xing Y, Qian Z. Newcastle disease virus activates macrophages for anti-tumor activity. Int J Oncol 2000; 16: 363-73.
31. Umansky, V., Shatrov, VA., Lehmann, V., Schirrmacher, V. Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B. Int Immun 1996; 8: 491-8.
32. Müllner N, Lázár Á, Hrabák A. Enhanced utilization and altered metabolism of arginine in inflammatory macrophages caused by raised nitric oxide synthesis. Int J Biochem Cell Biol 2002; 34: 1080-90.
33. Vray B, Hoebeke J, Saint-Guillain M, Leloup R, Strosberg AD. A new quantitative fluorimetric assay for phagocytosis of bacteria. Scand. J. Immunol. 1980; 11: 147-53.
34. Matsukawa A, Kudo S, Maeda T, Numata K, Watanabe H, Tamada K et al. Stat3 in resident macrophages as a repressor protein of inflammatory response. J Immunol 2005; 175: 3354-9.
35. Iniesta V, Gómez-Nieto GC, Molano I, Mohedano A, Carcelén J, Mirón C et al. Arginase I induction in macrophages, triggered by Th-2 type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002; 24: 113-8.
36. Zampetaki A, Mitsialis SA, Pfeilschifter J, Kourembanas S. Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-κB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J 2004; 18: 1090-2.
37. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 9730-4.
38. Yui S, Sasaki T, Yamazaki M. Augmentation and suppression of TNF release from macrophages by inflammatory polymorphonuclear leukocytes. Microbiol Immunol 1993; 37: 801-8.
39. Ohkura M, Fuchimoto S, Orita K. Antitumor effect of recombinant human interleukin-1beta alone and in combination with natural human tumor necrosis factor-alpha. Jpn J Cancer Res 1990; 81, 1026-31.
40. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-63.
41. Shibata Y, Henriksen RA, Honda I, Nakamura RM, Myrvik QN. Splenic PGE2-releasing macrophages regulate Th1 and Th2 immune responses in mice with heat-killed BCG. J Leukoc Biol 2005; 78: 1281-90.
42. Nagasaki A, Gotoh T, Takeya M, Yu Y, Takiguchi M, Matsuzaki H et al. Coinduction of nitric oxide synthase, argininosuccinate synthetase and argininosuccinate lyase in lipopolysaccharide treated rats. RNA blot, immunoblot and immunohistochemical analyses. J Biol Chem 1996; 271: 2658-72.
43. Benninghoff B, Dröge W, Lehmann V. The lipopolysaccharide-induced stimulation of peritoneal macrophages involves at least two signal pathways. Partial stimulation by lipid A precursors. Eur J Biochem 1989; 179: 589-94.
44. Sonoki T, Nagasaki A, Gotoh T, Takiguchi M, Takeya M, Matsuzaki H et al. Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J Biol Chem 1997; 272: 3689-93.
45. Ogata M, Yoshida S, Kamochi M, Shigematsu A, Mizuguchi Y. Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment. Infect Immun 1991; 59: 679-83.